{"id":"https://openalex.org/W2043766609","doi":"https://doi.org/10.2174/156801605774322292","title":"Clinical Determination of the Severity of Metabolic Syndrome: Preheparin Lipoprotein Lipase Mass as a New Marker of Metabolic Syndrome","display_name":"Clinical Determination of the Severity of Metabolic Syndrome: Preheparin Lipoprotein Lipase Mass as a New Marker of Metabolic Syndrome","publication_year":2005,"publication_date":"2005-09-28","ids":{"openalex":"https://openalex.org/W2043766609","doi":"https://doi.org/10.2174/156801605774322292","mag":"2043766609","pmid":"https://pubmed.ncbi.nlm.nih.gov/16250868"},"language":"en","primary_location":{"id":"doi:10.2174/156801605774322292","doi":"https://doi.org/10.2174/156801605774322292","is_oa":false,"landing_page_url":"https://doi.org/10.2174/156801605774322292","pdf_url":null,"source":{"id":"https://openalex.org/S4210196843","display_name":"Current Medicinal Chemistry - Cardiovascular & Hematological Agents","issn_l":"1568-0169","issn":["1568-0169","1875-6174"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core"],"host_organization":"https://openalex.org/P4310320079","host_organization_name":"Bentham Science Publishers","host_organization_lineage":["https://openalex.org/P4310320079"],"host_organization_lineage_names":["Bentham Science Publishers"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Current Medicinal Chemistry-Cardiovascular & Hematological Agents","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":null,"display_name":"Y. Miyashita","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I129634264","display_name":"Toho University","ror":"https://ror.org/02hcx7n63","country_code":"JP","type":"education","lineage":["https://openalex.org/I129634264"]},{"id":"https://openalex.org/I4210125448","display_name":"Toho University Medical Center Sakura Hospital","ror":"https://ror.org/02xrm8w90","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4210125448"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Y. Miyashita","raw_affiliation_strings":["Internal Medicine of Sakura Hospital, School of Medicine, Toho University, 564-1 Shimoshizu, Sakura-City, Chiba, 285-0841, Japan. mumon@sf6.so-net.ne.jp","Internal Medicine of Sakura Hospital, School of Medicine, Toho University, 564-1 Shimoshizu, Sakura-City, Chiba, 285-0841, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Internal Medicine of Sakura Hospital, School of Medicine, Toho University, 564-1 Shimoshizu, Sakura-City, Chiba, 285-0841, Japan. mumon@sf6.so-net.ne.jp","institution_ids":["https://openalex.org/I129634264","https://openalex.org/I4210125448"]},{"raw_affiliation_string":"Internal Medicine of Sakura Hospital, School of Medicine, Toho University, 564-1 Shimoshizu, Sakura-City, Chiba, 285-0841, Japan","institution_ids":["https://openalex.org/I129634264"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5111374229","display_name":"Kouji Shirai","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I129634264","display_name":"Toho University","ror":"https://ror.org/02hcx7n63","country_code":"JP","type":"education","lineage":["https://openalex.org/I129634264"]},{"id":"https://openalex.org/I4210125448","display_name":"Toho University Medical Center Sakura Hospital","ror":"https://ror.org/02xrm8w90","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4210125448"]}],"countries":["JP"],"is_corresponding":true,"raw_author_name":"K. Shirai","raw_affiliation_strings":["Internal Medicine of Sakura Hospital, School of Medicine, Toho University, 564-1 Shimoshizu, Sakura-City, Chiba, 285-0841, Japan.,Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Internal Medicine of Sakura Hospital, School of Medicine, Toho University, 564-1 Shimoshizu, Sakura-City, Chiba, 285-0841, Japan.,Japan","institution_ids":["https://openalex.org/I129634264","https://openalex.org/I4210125448"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5111374229"],"corresponding_institution_ids":["https://openalex.org/I129634264","https://openalex.org/I4210125448"],"apc_list":null,"apc_paid":null,"fwci":1.73,"has_fulltext":false,"cited_by_count":21,"citation_normalized_percentile":{"value":0.85748456,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":87,"max":95},"biblio":{"volume":"3","issue":"4","first_page":"377","last_page":"381"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T13430","display_name":"Lipid metabolism and disorders","score":0.9707000255584717,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T13430","display_name":"Lipid metabolism and disorders","score":0.9707000255584717,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10027","display_name":"Diabetes, Cardiovascular Risks, and Lipoproteins","score":0.02810000069439411,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10528","display_name":"Adipokines, Inflammation, and Metabolic Diseases","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/metabolic-syndrome","display_name":"metabolic syndrome","score":0.871999979019165},{"id":"https://openalex.org/keywords/insulin-resistance","display_name":"insulin resistance","score":0.8659999966621399},{"id":"https://openalex.org/keywords/serum-biomarkers","display_name":"serum biomarkers","score":0.6460000276565552},{"id":"https://openalex.org/keywords/lipoprotein-lipase","display_name":"lipoprotein lipase","score":0.8180000185966492},{"id":"https://openalex.org/keywords/triglycerides","display_name":"triglycerides","score":0.7649999856948853},{"id":"https://openalex.org/keywords/hdl-cholesterol","display_name":"HDL cholesterol","score":0.9539999961853027},{"id":"https://openalex.org/keywords/type-2-diabetes","display_name":"type 2 diabetes","score":0.9539999961853027},{"id":"https://openalex.org/keywords/insulin-sensitizers","display_name":"insulin sensitizers","score":0.8870000243186951},{"id":"https://openalex.org/keywords/visceral-fat","display_name":"visceral fat","score":0.9959999918937683},{"id":"https://openalex.org/keywords/coronary-artery-disease","display_name":"coronary artery disease","score":0.8820000290870667},{"id":"https://openalex.org/keywords/atherosclerotic-lesion-severity","display_name":"atherosclerotic lesion severity","score":0.8610000014305115}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8146616220474243},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.8122917413711548},{"id":"https://openalex.org/C2777391703","wikidata":"https://www.wikidata.org/wiki/Q1053470","display_name":"Insulin resistance","level":3,"score":0.8064907789230347},{"id":"https://openalex.org/C94879076","wikidata":"https://www.wikidata.org/wiki/Q420014","display_name":"Lipoprotein lipase","level":3,"score":0.7154146432876587},{"id":"https://openalex.org/C2780578515","wikidata":"https://www.wikidata.org/wiki/Q657193","display_name":"Metabolic syndrome","level":3,"score":0.7010267376899719},{"id":"https://openalex.org/C2778096610","wikidata":"https://www.wikidata.org/wiki/Q1476525","display_name":"Dyslipidemia","level":3,"score":0.6415454149246216},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.6187633275985718},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.5868264436721802},{"id":"https://openalex.org/C2778913445","wikidata":"https://www.wikidata.org/wiki/Q186319","display_name":"Triglyceride","level":3,"score":0.47558462619781494},{"id":"https://openalex.org/C2910068830","wikidata":"https://www.wikidata.org/wiki/Q3025883","display_name":"Type 2 Diabetes Mellitus","level":3,"score":0.4322487413883209},{"id":"https://openalex.org/C2780221984","wikidata":"https://www.wikidata.org/wiki/Q131191","display_name":"Body mass index","level":2,"score":0.4165894389152527},{"id":"https://openalex.org/C2778163477","wikidata":"https://www.wikidata.org/wiki/Q43656","display_name":"Cholesterol","level":2,"score":0.31245073676109314},{"id":"https://openalex.org/C171089720","wikidata":"https://www.wikidata.org/wiki/Q193583","display_name":"Adipose tissue","level":2,"score":0.26399463415145874}],"mesh":[{"descriptor_ui":"D003324","descriptor_name":"Coronary Artery Disease","qualifier_ui":"Q000201","qualifier_name":"enzymology","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008071","descriptor_name":"Lipoprotein Lipase","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D015415","descriptor_name":"Biomarkers","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D024821","descriptor_name":"Metabolic Syndrome","qualifier_ui":"Q000201","qualifier_name":"enzymology","is_major_topic":false},{"descriptor_ui":"D024821","descriptor_name":"Metabolic Syndrome","qualifier_ui":"Q000503","qualifier_name":"physiopathology","is_major_topic":true},{"descriptor_ui":"D050152","descriptor_name":"Intra-Abdominal Fat","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.2174/156801605774322292","doi":"https://doi.org/10.2174/156801605774322292","is_oa":false,"landing_page_url":"https://doi.org/10.2174/156801605774322292","pdf_url":null,"source":{"id":"https://openalex.org/S4210196843","display_name":"Current Medicinal Chemistry - Cardiovascular & Hematological Agents","issn_l":"1568-0169","issn":["1568-0169","1875-6174"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core"],"host_organization":"https://openalex.org/P4310320079","host_organization_name":"Bentham Science Publishers","host_organization_lineage":["https://openalex.org/P4310320079"],"host_organization_lineage_names":["Bentham Science Publishers"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Current Medicinal Chemistry-Cardiovascular & Hematological Agents","raw_type":"journal-article"},{"id":"pmid:16250868","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/16250868","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Current medicinal chemistry. Cardiovascular and hematological agents","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9940000176429749,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W1973870659","https://openalex.org/W1979575769","https://openalex.org/W76781471","https://openalex.org/W2028926882","https://openalex.org/W2134525708","https://openalex.org/W7096013433","https://openalex.org/W1991254921","https://openalex.org/W2507971842","https://openalex.org/W2069257634","https://openalex.org/W654265590"],"abstract_inverted_index":{"The":[0],"severity":[1,134],"of":[2,9,23,29,63,99,135,154,157],"metabolic":[3],"syndrome":[4],"depends":[5],"on":[6],"the":[7,60,133,149,158],"degree":[8],"insulin":[10,24,100,155],"resistance.":[11,25],"However,":[12],"currently":[13],"there":[14],"is":[15,35,49,77,88,95,115],"no":[16,127],"adequate":[17],"clinical":[18,61],"marker":[19],"for":[20],"quantitative":[21,152],"analysis":[22],"A":[26],"small":[27],"quantity":[28],"lipoprotein":[30],"lipase":[31],"(LPL)":[32],"protein,":[33],"which":[34],"an":[36,104],"inactive":[37],"form":[38],"and":[39,48,83,102,129],"commonly":[40],"called":[41],"'preheparin":[42],"LPL":[43,66,75,112,142],"mass',":[44],"exists":[45],"in":[46,69,90,118],"serum":[47,64,81],"detected":[50],"by":[51,97],"a":[52],"sensitive":[53],"immunoassay":[54],"system.":[55],"Recent":[56],"studies":[57],"have":[58],"reported":[59],"significance":[62],"preheparin":[65,74,111,141],"mass":[67,76,113,143],"levels":[68],"various":[70],"aspects.":[71],"For":[72],"example,":[73],"negatively":[78,131],"related":[79,85],"to":[80,86,124,147],"triglyceride":[82],"positively":[84],"HDL-cholesterol,":[87],"low":[89],"type":[91],"2":[92],"diabetes":[93],"mellitus,":[94],"increased":[96],"administration":[98],"sensitizer,":[101],"shows":[103],"inverse":[105],"relationship":[106],"with":[107,120,126,132],"visceral":[108],"adiposity.":[109],"Furthermore,":[110],"level":[114],"significantly":[116],"lower":[117],"patients":[119,125],"coronary":[121],"atherosclerosis":[122],"compared":[123],"lesion,":[128],"correlates":[130],"these":[136,139],"lesions.":[137],"From":[138],"reports,":[140],"may":[144],"be":[145,148],"considered":[146],"most":[150],"important":[151],"indicator":[153],"resistance":[156],"whole":[159],"body.":[160]},"counts_by_year":[{"year":2024,"cited_by_count":1},{"year":2022,"cited_by_count":2},{"year":2021,"cited_by_count":1},{"year":2012,"cited_by_count":1}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}